Literature DB >> 8512177

Altered calcium signaling and neuronal injury: stroke and Alzheimer's disease as examples.

M P Mattson1, R E Rydel, I Lieberburg, V L Smith-Swintosky.   

Abstract

Several cellular signaling systems have been implicated in the neuronal death that occurs both in development ("natural" cell death) or in pathological conditions such as stroke and Alzheimer's disease (AD). Here we consider the possibility that neuronal degeneration in an array of disorders including stroke and AD arises from one or more alterations in calcium-regulating systems that result in a loss of cellular calcium homeostasis. A long-standing hypothesis of neuronal injury, the excitatory amino acid (EAA) hypothesis, is revisited in light of new supportive data concerning the roles of EAAs in stroke and the neurofibrillary degeneration in AD. Two quite new concepts concerning mechanisms of neuronal injury and death are presented, namely: 1) growth factors normally "stabilize" intracellular free calcium levels ([Ca2+]i) and protect neurons against ischemic/excitotoxic injury, and 2) aberrant processing of beta-amyloid precursor protein (APP) can cause neurodegeneration by impairing a neuroprotective function of secreted forms of APP (APPs) which normally regulate [Ca2+]i. Altered APP processing also results in the accumulation of beta-amyloid peptide which contributes to neuronal damage by destabilizing calcium homeostasis; in AD beta-amyloid peptide may render neurons vulnerable to excitotoxic conditions that accrue with increasing age (e.g., altered glucose metabolism, ischemia). Growth factors may normally protect neurons against the potentially damaging effects of calcium influx resulting from energy deprivation and overexcitation. For example, bFGF, NGF and IGFs can protect neurons from several brain regions against excitotoxic/ischemic insults. Growth factors apparently stabilize [Ca2+]i by several means including: a reduction in calcium influx; enhanced calcium extrusion or buffering; and maintenance or improvement of mitochondrial function. For example, bFGF can suppress the expression of a N-methyl-D-aspartate (NMDA) receptor protein that mediates excitotoxic damage in hippocampal neurons. Growth factors may also prevent the loss of neuronal calcium homeostasis and the increased vulnerability to neuronal injury caused by beta-amyloid peptide. Since elevated [Ca2+]i can elicit cytoskeletal alterations similar to those seen in AD neurofibrillary tangles, we propose that neuronal damage in AD results from a loss of calcium homeostasis. The data indicate that a variety of alterations in [Ca2+]i regulation may contribute to the neuronal damage in stroke and AD, and suggest possible means of preventing neuronal damage in these disorders.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8512177     DOI: 10.1111/j.1749-6632.1993.tb18285.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  19 in total

1.  Changes in the expression of plasma membrane calcium extrusion systems during the maturation of hippocampal neurons.

Authors:  Sertac N Kip; Noah W Gray; Alain Burette; Ali Canbay; Richard J Weinberg; Emanuel E Strehler
Journal:  Hippocampus       Date:  2006       Impact factor: 3.899

Review 2.  Is there a future for cyclo-oxygenase inhibitors in Alzheimer's disease?

Authors:  Lap Ho; Weiping Qin; Breton S Stetka; Giulio M Pasinetti
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

3.  Use-dependent exaggeration of neuronal injury after unilateral sensorimotor cortex lesions.

Authors:  D A Kozlowski; D C James; T Schallert
Journal:  J Neurosci       Date:  1996-08-01       Impact factor: 6.167

4.  Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's disease.

Authors:  J P Sheehan; R H Swerdlow; S W Miller; R E Davis; J K Parks; W D Parker; J B Tuttle
Journal:  J Neurosci       Date:  1997-06-15       Impact factor: 6.167

5.  Dynorphin A (1-13) neurotoxicity in vitro: opioid and non-opioid mechanisms in mouse spinal cord neurons.

Authors:  K F Hauser; J K Foldes; C S Turbek
Journal:  Exp Neurol       Date:  1999-12       Impact factor: 5.330

6.  Alteration of phosphoinositide degradation by cytosolic and membrane-bound phospholipases after forebrain ischemia-reperfusion in gerbil: effects of amyloid beta peptide.

Authors:  J Strosznajder; A Zambrzycka; M D Kacprzak; D Kopczuk; R P Strosznajder
Journal:  Neurochem Res       Date:  1999-10       Impact factor: 3.996

Review 7.  Mechanisms of L-cysteine neurotoxicity.

Authors:  R Janáky; V Varga; A Hermann; P Saransaari; S S Oja
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

8.  Pulsatile shear stress leads to DNA fragmentation in human SH-SY5Y neuroblastoma cell line.

Authors:  D H Triyoso; T A Good
Journal:  J Physiol       Date:  1999-03-01       Impact factor: 5.182

9.  Age-related loss of calcium buffering and selective neuronal vulnerability in Alzheimer's disease.

Authors:  David Riascos; Dianne de Leon; Alaina Baker-Nigh; Alexander Nicholas; Rustam Yukhananov; Jing Bu; Chuang-Kuo Wu; Changiz Geula
Journal:  Acta Neuropathol       Date:  2011-08-27       Impact factor: 17.088

10.  Calcium regulates processing of the Alzheimer amyloid protein precursor in a protein kinase C-independent manner.

Authors:  J D Buxbaum; A A Ruefli; C A Parker; A M Cypess; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.